The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 58,301 | 1,378,600 | SH | SOLE | 1,378,600 | 0 | 0 | ||
AbbVie Inc. | Common | 00287Y109 | 10 | 156 | SH | SOLE | 156 | 0 | 0 | ||
Acadia Healthcare Company. Inc. | Common | 00404A109 | 1,744 | 35,200 | SH | SOLE | 35,200 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 3,556 | 111,800 | SH | SOLE | 111,800 | 0 | 0 | ||
Accelerate Diagnostics, Inc. | Common | 00430H102 | 3,271 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
Adaptimmune Theraputics plc | Sponsored ADR | 00653A107 | 3,993 | 566,368 | SH | SOLE | 566,368 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Note 2.00% 8/15/19 | 00767EAB8 | 8,572 | 13,000,000 | PRN | SOLE | 13,000,000 | 0 | 0 | ||
Affimed NV | Common | N01045108 | 818 | 294,213 | SH | SOLE | 294,213 | 0 | 0 | ||
Agilent Technologies, Inc. | Common | 00846U101 | 21,659 | 459,950 | SH | SOLE | 459,950 | 0 | 0 | ||
Akorn, Inc. | Common | 009728106 | 3,959 | 145,235 | SH | SOLE | 145,235 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 93,621 | 764,005 | SH | SOLE | 764,005 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 27,369 | 581,944 | SH | SOLE | 581,944 | 0 | 0 | ||
Allergan plc | Common | G0177J108 | 99,974 | 434,086 | SH | SOLE | 434,086 | 0 | 0 | ||
Allergan plc | Preferred Convertible | G0177J116 | 4,108 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
Alliqua BioMedical, Inc. | Common | 019621200 | 1,287 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | ||
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 2,286 | 173,600 | SH | SOLE | 173,600 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 16,538 | 243,995 | SH | SOLE | 243,995 | 0 | 0 | ||
AmerisourceBergen Corporation | Common | 03073E105 | 26,713 | 330,687 | SH | SOLE | 330,687 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 53,653 | 321,640 | SH | SOLE | 321,640 | 0 | 0 | ||
Amicus Therapeutics, Inc. | Common | 03152W109 | 1,909 | 258,000 | SH | SOLE | 258,000 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y407 | 2,344 | 811,227 | SH | SOLE | 811,227 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 9,157 | 707,636 | SH | SOLE | 707,636 | 0 | 0 | ||
ARIAD Pharmaceuticals, Inc. | Common | 04033A100 | 6,872 | 502,000 | SH | SOLE | 502,000 | 0 | 0 | ||
AstraZeneca PLC | Sponsored ADR | 046353108 | 15,240 | 463,800 | SH | SOLE | 463,800 | 0 | 0 | ||
Auris Medical Holding AG | Common | H03579101 | 1,340 | 774,504 | SH | SOLE | 774,504 | 0 | 0 | ||
Becton Dickinson and Company | Common | 075887109 | 11,337 | 63,078 | SH | SOLE | 63,078 | 0 | 0 | ||
BeiGene Ltd. | Sponsored ADR | 07725L102 | 3,596 | 116,707 | SH | SOLE | 116,707 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 1,194 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 150,891 | 482,033 | SH | SOLE | 482,033 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 65,703 | 710,145 | SH | SOLE | 710,145 | 0 | 0 | ||
bluebird bio, Inc. | Common | 09609G100 | 3,345 | 49,345 | SH | SOLE | 49,345 | 0 | 0 | ||
Cardinal Health, Inc. | Common | 14149Y108 | 11,849 | 152,500 | SH | SOLE | 152,500 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 155,132 | 1,484,089 | SH | SOLE | 1,484,089 | 0 | 0 | ||
Celldex Therapeutics, Inc. | Common | 15117B103 | 427 | 105,800 | SH | SOLE | 105,800 | 0 | 0 | ||
Cellectis S.A. | Sponsored ADR | 15117K103 | 7,471 | 310,250 | SH | SOLE | 310,250 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 17,175 | 256,500 | SH | SOLE | 256,500 | 0 | 0 | ||
Cepheid, Inc. | Common | 15670R107 | 17,577 | 333,590 | SH | SOLE | 333,590 | 0 | 0 | ||
Charles River Laboratories International, Inc. | Common | 159864107 | 9,584 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
Chimerix, Inc. | Common | 16934W106 | 1,711 | 308,892 | SH | SOLE | 308,892 | 0 | 0 | ||
Cidara Therapeutics, Inc. | Common | 171757107 | 1,517 | 132,472 | SH | SOLE | 132,472 | 0 | 0 | ||
Cigna Corporation | Common | 125509109 | 11,260 | 86,400 | SH | SOLE | 86,400 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 3,514 | 304,472 | SH | SOLE | 304,472 | 0 | 0 | ||
CVS Caremark Corporation | Common | 126650100 | 36,654 | 411,891 | SH | SOLE | 411,891 | 0 | 0 | ||
CytomX Therapeutics, Inc. | Common | 23284F105 | 11,855 | 756,090 | SH | SOLE | 756,090 | 0 | 0 | ||
DaVita, Inc. | Common | 23918K108 | 10,644 | 161,100 | SH | SOLE | 161,100 | 0 | 0 | ||
DBV Technologies | Sponsored ADR | 23306J101 | 2,383 | 65,600 | SH | SOLE | 65,600 | 0 | 0 | ||
Depomed, Inc. | Common | 249908104 | 4,998 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Dermira, Inc. | Common | 24983L104 | 2,794 | 82,600 | SH | SOLE | 82,600 | 0 | 0 | ||
Diplomat Pharmacy, Inc. | Common | 25456K101 | 2,441 | 87,163 | SH | SOLE | 87,163 | 0 | 0 | ||
Dynavax Technologies Corporation | Common | 268158201 | 3,620 | 345,050 | SH | SOLE | 345,050 | 0 | 0 | ||
Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | 5,963 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
Eli Lilly & Company | Common | 532457108 | 57,287 | 713,767 | SH | SOLE | 713,767 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 18,428 | 914,548 | SH | SOLE | 914,548 | 0 | 0 | ||
Endologix, Inc. | Common | 29266S106 | 9,901 | 773,500 | SH | SOLE | 773,500 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 3,936 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Esperion Therapeutics, Inc. | Common | 29664W105 | 1,424 | 102,800 | SH | SOLE | 102,800 | 0 | 0 | ||
Exelixis, Inc. | Common | 30161Q104 | 7,056 | 551,647 | SH | SOLE | 551,647 | 0 | 0 | ||
Flamel Technologies SA | Sponsored ADR | 338488109 | 7,741 | 624,288 | SH | SOLE | 624,288 | 0 | 0 | ||
Flex Pharma, Inc. | Common | 33938A105 | 1,910 | 162,124 | SH | SOLE | 162,124 | 0 | 0 | ||
Foamix Pharmaceuticals, Ltd. | Shares | M46135105 | 8,946 | 966,065 | SH | SOLE | 966,065 | 0 | 0 | ||
Forward Pharma A/S | Sponsored ADR | 34986J105 | 2,867 | 136,547 | SH | SOLE | 136,547 | 0 | 0 | ||
Galapagos NV | Sponsored ADR | 36315X101 | 9,553 | 147,738 | SH | SOLE | 147,738 | 0 | 0 | ||
GenMark Diagnostics, Inc. | Common | 372309104 | 1,102 | 93,349 | SH | SOLE | 93,349 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 210,470 | 2,660,131 | SH | SOLE | 2,660,131 | 0 | 0 | ||
GlaxoSmithKline plc | Sponsored ADR | 37733W105 | 15,484 | 359,000 | SH | SOLE | 359,000 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | Common | 37890U108 | 2,881 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Grifols SA | Sponsored ADR | 398438408 | 2,651 | 166,000 | SH | SOLE | 166,000 | 0 | 0 | ||
Halozyme Therapeutics, Inc. | Common | 40637H109 | 2,416 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
HCA Holdings, Inc. | Common | 40412C101 | 7,237 | 95,684 | SH | SOLE | 95,684 | 0 | 0 | ||
Horizon Pharma plc | Shares | G4617B105 | 13,596 | 749,900 | SH | SOLE | 749,900 | 0 | 0 | ||
Humana, Inc. | Common | 444859102 | 29,151 | 164,800 | SH | SOLE | 164,800 | 0 | 0 | ||
ICON plc | Shares | G4705A100 | 5,571 | 72,000 | SH | SOLE | 72,000 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 14,920 | 132,352 | SH | SOLE | 132,352 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 44,790 | 246,560 | SH | SOLE | 246,560 | 0 | 0 | ||
Immunomedics, Inc. | Note 4.75% 2/15/20 | 452907AK4 | 3,378 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | ||
Impax Laboratories, Inc. | Common | 45256B101 | 2,947 | 124,335 | SH | SOLE | 124,335 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 83,019 | 880,461 | SH | SOLE | 880,461 | 0 | 0 | ||
Inotek Pharmaceuticals Corporation | Common | 45780V102 | 1,714 | 180,762 | SH | SOLE | 180,762 | 0 | 0 | ||
Intellia Therapeutics, Inc. | Common | 45826J105 | 1,223 | 71,842 | SH | SOLE | 71,842 | 0 | 0 | ||
iShares Nasdaq Biotechnology ETF | ETF | 464287556 | 16,693 | 57,670 | SH | SOLE | 57,670 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 40,260 | 331,411 | SH | SOLE | 331,411 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 39,847 | 337,312 | SH | SOLE | 337,312 | 0 | 0 | ||
Juno Therapeutics, Inc. | Common | 48205A109 | 5,462 | 182,000 | SH | SOLE | 182,000 | 0 | 0 | ||
Karyopharm Therapeutics, Inc. | Common | 48576U106 | 4,868 | 500,324 | SH | SOLE | 500,324 | 0 | 0 | ||
LTC Properties, Inc. | Common | 502175102 | 5,522 | 106,212 | SH | SOLE | 106,212 | 0 | 0 | ||
Mallinckrodt plc | Shares | G5785G107 | 4,319 | 61,900 | SH | SOLE | 61,900 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 2,501 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 12,395 | 839,217 | SH | SOLE | 839,217 | 0 | 0 | ||
The Medicines Company | Common | 584688105 | 21,302 | 564,438 | SH | SOLE | 564,438 | 0 | 0 | ||
Medtronic plc | Shares | G5960L103 | 53,830 | 623,030 | SH | SOLE | 623,030 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 77,788 | 1,246,397 | SH | SOLE | 1,246,397 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Note 4.50% 7/15/20 | 590328AA8 | 1,879 | 1,485,000 | PRN | SOLE | 1,485,000 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Common | 590328100 | 1,816 | 286,000 | SH | SOLE | 286,000 | 0 | 0 | ||
Merus B.V. | Common | N5749R100 | 4,355 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
Molina Healthcare, Inc. | Common | 60855R100 | 23,476 | 402,541 | SH | SOLE | 402,541 | 0 | 0 | ||
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 1,797 | 153,700 | SH | SOLE | 153,700 | 0 | 0 | ||
Mylan NV | Shares | N59465109 | 43,287 | 1,135,552 | SH | SOLE | 1,135,552 | 0 | 0 | ||
Natera, Inc. | Common | 632307104 | 9,803 | 882,358 | SH | SOLE | 882,358 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 33,251 | 656,622 | SH | SOLE | 656,622 | 0 | 0 | ||
Nevro Corp. | Common | 64157F103 | 2,610 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
New Senior Investment Group Inc. | Common | 648691103 | 4,974 | 430,997 | SH | SOLE | 430,997 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 19,645 | 248,800 | SH | SOLE | 248,800 | 0 | 0 | ||
Novavax, Inc. | Common | 670002104 | 1,188 | 571,000 | SH | SOLE | 571,000 | 0 | 0 | ||
Omega Healthcare Investors, Inc. | Common | 681936100 | 14,645 | 413,116 | SH | SOLE | 413,116 | 0 | 0 | ||
Paratek Pharmaceuticals, Inc. | Common | 699374302 | 9,921 | 762,581 | SH | SOLE | 762,581 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 3,444 | 37,300 | SH | SOLE | 37,300 | 0 | 0 | ||
Pfizer Inc. | Common | 717081103 | 38,838 | 1,146,689 | SH | SOLE | 1,146,689 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 11,431 | 530,672 | SH | SOLE | 530,672 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 7,587 | 4,145,958 | SH | SOLE | 4,145,958 | 0 | 0 | ||
PRA Health Sciences, Inc. | Common | 69354M108 | 5,764 | 102,000 | SH | SOLE | 102,000 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 17,446 | 260,200 | SH | SOLE | 260,200 | 0 | 0 | ||
Quorum Health Corporation | Common | 74909E106 | 477 | 76,118 | SH | SOLE | 76,118 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 62,018 | 154,266 | SH | SOLE | 154,266 | 0 | 0 | ||
Retrophin, Inc. | Common | 761299106 | 7,384 | 329,949 | SH | SOLE | 329,949 | 0 | 0 | ||
Revance Therapeutics, Inc. | Common | 761330109 | 1,216 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
The RMR Group Inc. | Class A | 74967R106 | 282 | 7,441 | SH | SOLE | 7,441 | 0 | 0 | ||
Sabra Health Care REIT, Inc. | Common | 78573L106 | 11,487 | 456,190 | SH | SOLE | 456,190 | 0 | 0 | ||
Sage Therapeutics, Inc. | Common | 78667J108 | 6,760 | 146,800 | SH | SOLE | 146,800 | 0 | 0 | ||
Sanofi | Sponsored ADR | 80105N105 | 11,648 | 305,000 | SH | SOLE | 305,000 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | Common | 803607100 | 13,148 | 214,100 | SH | SOLE | 214,100 | 0 | 0 | ||
Senior Housing Properties Trust | Shares | 81721M109 | 13,059 | 575,054 | SH | SOLE | 575,054 | 0 | 0 | ||
Shire plc | Sponsored ADR | 82481R106 | 44,862 | 231,413 | SH | SOLE | 231,413 | 0 | 0 | ||
Supernus Pharmaceuticals, Inc. | Note 7.50% 5/1/19 | 868459AB4 | 9,334 | 2,000,000 | PRN | SOLE | 2,000,000 | 0 | 0 | ||
Tenet Healthcare Corporation | Common | 88033G407 | 3,728 | 164,500 | SH | SOLE | 164,500 | 0 | 0 | ||
Tetraphase Pharmaceuticals Inc. | Common | 88165N105 | 737 | 192,322 | SH | SOLE | 192,322 | 0 | 0 | ||
Teva Pharmaceutical Industries Limited | Sponsored ADR | 881624209 | 36,300 | 788,958 | SH | SOLE | 788,958 | 0 | 0 | ||
TherapeuticsMD, Inc. | Common | 88338N107 | 2,091 | 307,000 | SH | SOLE | 307,000 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 13,742 | 86,395 | SH | SOLE | 86,395 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 6,271 | 88,400 | SH | SOLE | 88,400 | 0 | 0 | ||
UniQure NV | Shares | N90064101 | 1,844 | 241,021 | SH | SOLE | 241,021 | 0 | 0 | ||
United Therapeutics Corporation | Common | 91307C102 | 10,993 | 93,100 | SH | SOLE | 93,100 | 0 | 0 | ||
Unitedhealth Group, Inc. | Common | 91324P102 | 46,354 | 331,100 | SH | SOLE | 331,100 | 0 | 0 | ||
Universal Health Services, Inc. | Class B | 913903100 | 16,595 | 134,680 | SH | SOLE | 134,680 | 0 | 0 | ||
Valeant Pharmaceuticals International, Inc. | Common | 91911K102 | 4,714 | 192,000 | SH | SOLE | 192,000 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 10,770 | 152,491 | SH | SOLE | 152,491 | 0 | 0 | ||
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 90,132 | 1,033,503 | SH | SOLE | 1,033,503 | 0 | 0 | ||
Vitae Pharmaceuticals, Inc. | Common | 92847N103 | 5,230 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Welltower, Inc. | Preferred Convertible | 95040Q203 | 13,310 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Xencor, Inc. | Common | 98401F105 | 490 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 5,670 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
Zafgen, Inc. | Common | 98885E103 | 44 | 13,307 | SH | SOLE | 13,307 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 13,301 | 102,300 | SH | SOLE | 102,300 | 0 | 0 |